Fred Lyagoba
- Co-authors
- Pontiano KaleebuDavid YirrellAlleluiah RutebemberwaDilys MorganCharles F. GilksNeil FrenchJonathan WeberChristine Watera
- Topics
- HIV Research and Treatment (18 papers)HIV/AIDS Research and Interventions (14 papers)HIV/AIDS drug development and treatment (13 papers)
- Partner nations
- UgandaUnited KingdomUnited States
In The Last Decade
Fred Lyagoba
22 papers receiving 583 citations
Peers
Comparison fields: 5 of 62
- Virology 506
- Infectious Diseases 477
- Epidemiology 117
- Immunology 52
- Molecular Biology 50
Countries citing papers authored by Fred Lyagoba
This map shows the geographic impact of Fred Lyagoba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred Lyagoba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred Lyagoba more than expected).
Fields of papers citing papers by Fred Lyagoba
This network shows the impact of papers produced by Fred Lyagoba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred Lyagoba. The network helps show where Fred Lyagoba may publish in the future.
Co-authorship network of co-authors of Fred Lyagoba
This figure shows the co-authorship network connecting the top 25 collaborators of Fred Lyagoba. A scholar is included among the top collaborators of Fred Lyagoba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fred Lyagoba. Fred Lyagoba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 28 | |
| 2 | 4 | |
| 3 | 11 | |
| 4 | 11 | |
| 5 | 15 | |
| 6 | 21 | |
| 7 | 22 | |
| 8 | 26 | |
| 9 | 26 | |
| 10 | 10 | |
| 11 | 21 | |
| 12 | 43 | |
| 13 | Prevalence and in vitro characteristics of reverse transcriptase (RT) N348I mutation in non-B subtypes, in the absence of viral load monitoring, in the DART Study (NORA substudy). | 2 |
| 14 | Differences in the dynamics of viral rebound and evolution of resistance between CBV/NVP and CBV/ABC (NORA sub study of DART trial) uncovered in the absence of viral load monitoring in real time. | 1 |
| 15 | Discordance between virological/immunological and clinical outcomes at 48 weeks, in a randomised comparison of ZDV/3TC/NVP and ZDV/3TC/ABC in patients with low CD4 counts in Africa. | 1 |
| 16 | Emergence and evolution of drug resistance in the absence of viral load monitoring during 48 weeks of Combivir/Tenofovir within the DART Trial. | 8 |
| 17 | 200 | |
| 18 | 91 | |
| 19 | 12 | |
| 20 | 35 |
About Fred Lyagoba
Fred Lyagoba is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 22 papers that have together received 596 indexed citations. Recurring topics across this work include HIV Research and Treatment (18 papers), HIV/AIDS Research and Interventions (14 papers) and HIV/AIDS drug development and treatment (13 papers). The work is most often cited by research in Virology (506 citations), Infectious Diseases (477 citations) and Emergency Medicine (42 citations). Fred Lyagoba has collaborated with scholars based in Uganda, United Kingdom and United States. Frequent co-authors include Pontiano Kaleebu, David Yirrell, Alleluiah Rutebemberwa, Dilys Morgan, Charles F. Gilks, Neil French, Jonathan Weber, Christine Watera, Jimmy Whitworth and Jessica Nakiyingi. Their work appears in journals such as PLoS ONE, The Journal of Infectious Diseases and AIDS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.